AIS's Health Business Daily is a daily email newsletter with strategic business stories written by experienced AIS Health reporters, as well as other information of interest to health care business leaders — including news from the nation’s leading health insurers, developments from the federal and state governments that impact the health care industry, and exclusive datapoints from Subscribe now to get an issue delivered to your inbox every morning!
October 11, 2017
Headlines in the News
Associated Press, Oct. 10, 2017
Quest Diagnostics

Today's AIS Health Datapoint
39% ... of formularies do not cover Pennsaid, making it the least likely acute pain drug to be covered by all payers and PBMs. The brand name acute pain drug most likely to be covered on the preferred tier is Voltaren, which has that status on 27% of formularies.
SOURCE: MMIT Analytics, as of Sept. 26, 2017

Quote of the Day
“You could imagine a world of Medicare for all having public option/private option components and a premium support model that might encourage people to go into the private plans if they cost less than the public option.”
— Bob Atlas, president of the EBG Advisors unit of health care law firm Epstein Becker & Green, tells AIS Health about a potentially more palatable version of Sen. Bernie Sanders’ Medicare-for-All proposal.

The Featured Story of the day may be accessed on the day it is transmitted without logging in to Thereafter, you may need to log in to access the Featured Story. If you haven’t yet registered on, please take a minute to create a free account now and get free access to thousands of articles, blogs and much more.

Questions or suggestions about the content in AIS's HEALTH BUSINESS DAILY should be directed to Executive Editor Jill Brown at

AIS's HEALTH BUSINESS DAILY is copyrighted and protected by federal law. The re-use of its content is restricted (see below). However, you are permitted to forward this email to as many of your friends and colleagues as you wish, or better yet have them sign up for their own copy at atlantic_subscription.cfm

Copyright © 2017 Managed Markets Insight & Technology, LLC. All rights reserved. It is not permissible to include all or any portion of this content on any Web site, intranet or electronic network or in any print publication, without AIS's written permission in advance. Permission requests should be directed to